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dementia: a comparative study
Lars-Olof Wahlund, Per Julin, Sven-Erik Johansson, Philip Scheltens
Abstract
Objectives—It has been shown that atro-
phy of medial temporal lobe structures
such as the hippocampus and entorhinal
cortex shown on MRI may distinguish
patients with Alzheimer’s disease from
healthy controls. However, the diagnostic
value of visual inspection and volumetry
of medial temporal lobe atrophy (MTA) on
MRI in a clinical setting is insuYciently
known.
Methods—Medial temporal lobe atrophy
in 143 patients was visually rated from
hard copies, using a 0–4 rating scale and a
comparison was made with the volumes
(cm3) of the medial temporal lobe as esti-
mated with volumetry, using a stereologi-
cal method. All patients were recruited in
an unselected way in a clinical setting in
the centre for memory impairments at the
Huddinge University Hospital. Patients
with Alzheimer’s disease (n=41), patients
with other dementias (vascular dementia,
frontotemporal dementia, and unspecified
dementia; n=36) as well as non-demented
subjects (n=66) were included. Medial
temporal atrophy and volumetry were
evaluated as a diagnostic tool by perform-
ing logistic regression analysis including
age, sex, and mini mental state examina-
tion (MMSE) score and calculating the
sensitivity and specificity and percentage
correct classification.
Results—Visual and volumetric analysis
yielded statistically significant diVerences
between patients with Alzheimer’s disease
and non-demented subjects, as well as
between those with other dementias and
non-demented subjects. Combining
MMSE scores and visually rated MTA rat-
ings yielded a sensitivity of 95% for
Alzheimer’s disease, 85% for other de-
mentias. Non-demented subjects were
identified with a specificity of 96%.Volum-
etry did not have an added value over the
MMSE score alone.
Conclusions—Visual rating of MTA is a
clinically useful method for diVerentiating
Alzheimer’s disease from controls and is
both quicker and more accurate than vol-
umetry.
(J Neurol Neurosurg Psychiatry 2000;69:630–635)
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Magnetic resonance imaging (MRI) has be-
come a complementary diagnostic tool in the
evaluation of dementia.1 Many studies have
shown that medial temporal lobe atrophy
(MTA) is a sensitive marker for Alzheimer’s
disease.2 3 To estimate MTA several techniques
are available—namely, volumetric assessment,
linear assessment, and visual qualitative rating.4
Volumetric assessment techniques are mainly
used in studies on selected groups of patients
and controls. These measurement techniques
rely on specifically developed software and are
undertaken separately from the clinical exam-
ination procedures using postprocessing equip-
ment.
The evaluation of MTA as a tool in the diag-
nostic procedure of dementia in a clinical rou-
tine setting is far from complete. A clinically
accessible method for estimation of MTA must
be rapid, simple, and reliable, to be used
together with the clinical and neuroradiological
examinations. Moreover, the method must be
able to diVerentiate between Alzheimer’s dis-
ease and other dementias as well as between
Alzheimer’s disease and non-demented sub-
jects. A visual rating scale of MTA, with an
acceptable within and between rater reliability,
has been developed by Scheltens et al.5 6 In a
recent study,7 this method was found to corre-
late well with stereological assessments of
MTA in a large (n=194) sample of demented
and non-demented subjects. Visually rated
MTA was shown to have moderate sensitivity
and specificity for Alzheimer’s disease in small
selected (five) and unselected (three) samples.
Earlier volumetric work showed that volumetry
could distinguish patients with Alzheimer’s
disease from controls with sensitivity and
specificity figures over 80%,8 but the distinc-
tion with other types of dementia yielded lower
figures.9 10
To investigate further the diagnostic capacity
of the visually rated MTA and to compare it
with volumetry we used both methods in a
large number of consecutive patients screened
for dementia. We compared specificity, sensi-
tivity, and percentage correct classification of
both methods using the ultimate clinical
diagnosis at follow up as the gold standard.
Material and methods
SUBJECTS
The patients enrolled in this study have been
described in detail previously.7 Here we present
the results from a subsample of this population.
The diagnostic procedure was as follows. All
patients referred for dementia investigation at
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the geriatric clinic at Huddinge University
Hospital from 1993 to 1995 were enrolled in
the study. A validated Swedish version of the
mini mental state examination (MMSE)11 was
used as the standard screening instrument. The
investigation further included a complete
physical, psychiatric, and neurological exam-
ination as well as comprehensive psychometric
tests. Brain MRI was performed as routine to
exclude other brain pathology. In addition, in
each patient blood and CSF samples were col-
lected and an EEG and SPECT scan were per-
formed. A cohort consisting of subjects se-
lected as control persons in a study on car
driving and dementia12 and of members of the
family with an APP mutation who were not
mutation carriers, were subjected to the same
procedure (except for SPECT ).
After this procedure all subjects were diag-
nosed using the guidelines in DSM-III-R13 for
assessing dementia, the NINDS-AIREN crite-
ria for vascular dementia,14 the Lund-
Manchester criteria for frontal lobe dementia,15
the ICD-10 criteria16 for unspecified dementia,
and the NINCDS-ADRDA17 criteria for
probable/possible Alzheimer’s disease. If none
of these diagnoses was applicable the subject
was designated as non-demented. After the
diagnostic investigation 10 patients had to be
excluded because of a space occupying lesion
and another nine were excluded because of
poor MRI quality, yielding 143 subjects whose
diagnoses were confirmed at follow up exami-
nations 6 months after the initial investigation
(table 1).
MAGNETIC RESONANCE IMAGING
All examinations were performed with a
Siemens 1.5 Tesla Magnetom. A standard
examination was first performed obtaining 24
T2 and proton density weighted, transaxial
images through the brain. The volumetric
measurements were based on a 3D magnetisa-
tion prepared rapid gradient echo sequence
(3D MP-RAGE, TR=10 ms, TE=4 ms, flip
angle=10°). This sequence yields 64 continu-
ous coronal slices covering the whole brain
with a good separation of grey and white mat-
ter and between brain tissue and CSF (T1
weighted). The slice thickness was 2.8 mm and
the partial volume eVect was small. The
coronal plane was chosen to be perpendicular
to the line intersecting the anterior and poste-
rior commissures in the midsagittal plane (the
AC-PC line).
VOLUMETRIC ESTIMATION
A description of the method has been pub-
lished previously.7 The volumetric measure-
ments were performed using the method of
stereology with a program, CV-Stereo, devel-
oped by Context Vision AB, Linköping,
Sweden. The point counting stereological
method used in this program is based on the
Cavalieri theorem of systematic sampling. The
computer program generated a grid which was
randomly placed on the MRI slices, and the
number of intersecting points over the area of
interest were counted. The size of the grid
depends on the the structure to be measured;
as a rule of thumb the total number of test
points should be around 100 to give a reason-
able accuracy. The volume was estimated with
the following formula: (number of measured
points)×(area of a square in the grid)×(distance
between slices). The requirements for this
method is that the structure should be sampled
at equal and perpendicular intervals, and the
sampling should begin at random. The above
described imaging technique meets the basic
requirements for the stereological method, as
the first slice intersects the brain at random.
The medial temporal lobe including the
amygdala, hippocampus, and parahippocampal
gyrus, was measured in 10 slices between the
anterior commissure and posterior commis-
sure, using a point distance of 0.5 cm in the test
point grid. The intracranial volume (ICV) was
defined as the whole volume inside the skull
with the lower border defined by the caudal
region of the cerebellum, temporal lobes, and
orbitofrontal cortex. The brain stem was not
included in the ICV. The ICV volume was
measured in eight slices with a test point grid of
2 cm. The within rater variation between two
measurements on the same image set was 3.5%
The within rater variation defined as the mean
diVerence between two measurements done by
one operator on two diVerent image sets of six
subjects being examined twice in the MRI
scanner with a time gap of 2 weeks, was 3.5%.
As these variations were identical, the measure-
ments seemed to be relatively independent for
image quality and positioning of the patient in
the scanner. The between rater variability
between two raters on scans of six subjects was
4.5%. The stereological method has also been
compared with a method using manual outlin-
ing plus thresholding.18 In 28 patients investi-
gated for suspected dementia bilateral medial
temporal lobe volumes were measured with
both methods. The stereological method gave
systematically lower medial temporal lobe
(MTL) volumes with a mean volume in the
patient group of 13,3 cm3 (SD 2.2) compared
with 14.9 cm3 (SD 2.4) with manual outlining
plus thresholding. This diVerence (−1.6 cm3)
was statistically significant (p< 0,001, paired t
test). The correlations between the two meth-
ods were high (0.84, p<0,001, Pearsson corre-
lation coeYcient 0.71, p<0.001 within class
correlation (Kendall ô)). Sex diVerences were
also detected by the two methods. Men (n=11)
had a 2.9 cm3 larger MTL than women (n=17)
using manual outlining+thresholding and a 2.2
cm3 larger MTL using stereology. Both diVer-
ences were statistically significant (p<0.01, t
test). These data clearly showed that despite
the not surprising systematic diVerence be-
tween the two methods there was a good
Table 1 Demographic data on the study groups
Diagnosis n (M/F) Age (SD) MMSE (SD)
AD 41 (16/25)* 62.6 ( 8.5) 18.1 (6.0)
OD 35 (21/15) 69.0 (9.2)† 21.6 (5.2)
ND 67 (38/29) 67.5 (11.5) 28.5 (1.6)
AD=Alzheimer’s disease; OD=other dementias (see text);
ND=non-demented subjects; MMSE=mini mental state exam-
ination.
*AD v OD and ND (p<0.01 for both, ÷2).
†OD v AD (p< 0.02, ANOVA).
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agreement in ranking the relative relation
between volumes within the group. This means
that the faster stereology method should be
comparable with manual outlining methods for
sensitivity.
VISUAL RATING
The MTA was assessed visually by one rater
(PS), who was blinded to the subjects’ age,
diagnosis, and sex. Scores ranged from 0 (no
atrophy) to 4 (severe atrophy). The rating scale
is based on a visual estimation of both the vol-
ume of the medial temporal lobe, including the
hippocampus proper, dentate gyrus, subicu-
lum, and parahippocampal gyrus and the
volume of the surrounding CSF spaces, in par-
ticular the temporal horn of the lateral ventricle
and the choroid fissure on both sides, left and
right side separately.5 Rating was performed on
T1 weighted coronal slices (hard copies)
according to example images published
earlier.6 This visual method of scoring has a
reasonably good between and within rater
reliability.6 For this study a modification was
made to rate left and right MTA separately.
STATISTICAL METHODS
One way ANOVA and ÷2 were used for group
comparisons. Tukey-Kramer HSD was used for
pairwise comparisons. The discriminative power
of volumetry and visual rating between the pair-
wise combinations of groups (Alzheimer’s
disease-non-demented, Alzheimer’s disease-
other dementias, and other dementias-non-
demented) were analyzed by using three logistic
regression models (main eVect models). The
first model included MMSE score only, the sec-
ond model MMSE score and volumetry and the
third MMSE score and visual rating (left and
right combined). We wanted to test the discrimi-
native power only of MMSE, volumetry, and
visual rating and not of age and sex. For this rea-
son we decided not to include them into the
models and found this to be justified by the
finding that including age and sex into the mod-
els resulted in only marginal changes.
The volumetry variables were continuous
and the visual rating variable comprised three
categories: 0 (reference), 1, and >1. The cross
classification was based on the estimated logis-
tic probabilities from the three models. The
chosen cut oV point was 0.5. Those with
predicted probabilities above 0.5 were classi-
fied into one group and those below 0.5 into a
second group. The results are shown as
sensitivity, specificity, and an overall rate of
correct classification (percentage), calculated
from the cross classification of observed and
predicted group membership. In addition, 95%
confidence intervals (95% CIs) were calculated
according to the method described by Car-
rington Reid19 as follows: sensitivity±1.96
(sensitivity×(1−sensitivity)/n). A p value>0.05
was considered not significant.
Results
The demographic data of the study group is
presented in table 1. The results of the visual
ratings and volumetry are presented in tables 2
and 3. Both methods yielded statistically
significant diVerences between the diagnostic
groups and non-dementias, but not between
Alzheimer’s disease and other dementias. The
patients with Alzheimer’s disease showed
significantly smaller MTA volumes than those
with non-dementias measured both visually
and with volumetry. Also the other dementias
group had smaller MTA than the non-
dementias group.
The first model including the variable for
MMSE score was significant in all compari-
sons. In the second and third models, the vari-
able for MMSE score and volumetry/visual
rating were significant (comparing Alzheimer’s
disease and non-dementias, and other demen-
tias and non-dementias). When comparing
Alzheimer’s disease and other dementias only
the variable for MMSE score was significant.
Thus the final diagnostic accuracy was calcu-
lated using the scond and third logistic
regression models adjusting for MMSE score.
In tables 4–6 the specificity, sensitivity, and
Table 2 Distribution of the rating of MTA in the study
groups AD,OD, and ND (left/right)
Score/
diagnosis 0 1 2 3 4 Total
AD 2/2 14/13 12/13 10/8 2/3 40
OD 4/4 8/8 13/13 6/7 3/2 34
ND 23/23 29/29 4/4 0/0 0/0 56
130
AD=Alzheimer’s disease; OD=other dementias (see text);
ND=non-demented subjects.÷2 test: AD v ND p<0.0001 (left
and right); AD v OD p>0.05 (left and right); OD v ND
p<0.0001 (left and right). Thirteen scans could not be rated for
technical reasons.
Table 3 Volumetry in AD,OD, and ND
Volumetry left
MTL/ICV
Volumetry right
MTL/ICV
AD (n=41) 0.0037 (0.00053) 0.0038 (0.00047)
OD (n=32) 0.0038 (0.00060) 0.0038 (0.00045)
ND (n=66) 0.0041 (0.00041) 0.0042 (0.00042)
Values are means (SD). AD=Alzheimer’s disease; OD=other
dementias (see text); ND=non-demented subjects.
MTL=medial temporal lobe (see text); ICV=intracranial
volume; ÷2: AD v ND p<0.0001 (left and right); AD v OD
p>0.05 (left and right); OD v ND p<0.0001 (left and right).
Four scans could not be measured for technical reasons.
Table 4 Diagnostic value for volumetry and visual rating of MTA.
AD v ND
MMSE
Left/Right MTA
MMSE+volumetry MMSE+visual rating
Sensitivity 81 (7) 88 (6)/90 (6) 93 (5)/92 (5)
Specificity 95 (4) 96 (4)/95 (4) 98 (3)/98 (3)
Correct classification 90 (46) 93 (5)/93 (4) 96 (4)/96 (4)
AD=Alzheimer’s disease; ND= non-dementias; AD and ND were compared. Sensitivity, specifi-
city, and correct classification are given in % (1.96 SE)
Table 5 Diagnostic value of volumetry and visual rating of MTA
OD v ND
MMSE
Left/Right MTA
MMSE+volumetry MMSE+visual rating
Sensitivity 75 (8) 78 (8)/78 (8) 82 (7)/82 (7)
Specificity 96 (4) 96 (4)/95 (6) 95 (4)/95 (4)
Correct classification 88 (6) 90 (6)/89 (6) 90 (6)/90 (6)
OD=other dementias; ND=non-dementias; OD and ND were compared. Sensitivity, specificity,
and correct classification are given in % (1.96 SE).
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percentage correct classification, based on the
three models, are given. The tables show that
visual rating yielded a diagnostic gain for
Alzheimer’s disease over the MMSE, whereas
volumetry did not. In separating the other
dementias from non-dementias, visual rating
added almost 30% to the sensitivity, but noth-
ing to the specificity, whereas volumetry did
not add to the MMSE despite the significant
variables. In distinguishing Alzheimer’s disease
from other dementias both MTA assessments
had no further predictive value (non-significant
variables) over MMSE score, adjusted for sex
and age.
To further clarify the results of the logistic
models we plotted the predicted probability for
each subject to group membership (only
Alzheimer’s disease or control) in the figure
A–C.
The actual time needed for volumetry (only
the point counting of the medial temporal lobes
and the volume) was 10–12 minutes/subject
and for visual rating 1–2 minutes/subject.
Discussion
In this study we compared two methods for
measuring medial temporal lobe atrophy in a
large sample of patients evaluated for demen-
tia. We found that both methods yielded
significant diVerences in patients with
Alzheimer’s disease compared with patients
with other dementias and non-dementias.
However, in terms of diagnostic gain over the
screening MMSE score only, visually rated
MTA added to the sensitivity in separating
Alzheimer’s disease and other dementias from
non-dementias. Visually rated MTA also added
to the sensitivity in discriminating Alzheimer’s
disease from other dementias whereas volu-
metric MTA assessments had a limited value in
this.
We investigated patients who were referred
to our clinic for evaluation of suspected
dementia. The patients were unselectively and
consecutively recruited and no exclusions were
made except for secondary dementias (n=10)
and those patients for whom the MR images
were of poor quality (n=9). By doing this we
tested the methods in a true clinical setting.
Using the clinical diagnosis made by clinicians
not involved in this study at follow up and hav-
ing the MR images evaluated by researchers
unaware of the clinical data, we aimed to avoid
investigation and review bias.19 In addition we
focused on the clinical usefulness of the meth-
ods, defined in this context as a method that is
both easy to use and gives satisfactory discrimi-
native power. To this end we used a diVerent
way of evaluating the sensitivity and specificity
for the methods by including a comparison
with the discriminative power of MMSE
scores, to reflect more the clinical decision
making situation, in which the MMSE is
usually done before ancillary studies are
ordered. Moreover, a comparison was made
Table 6 Diagnostic value of volumetry and visual rating of MTA
AD v OD
MMSE
Left/Right MTA
MMSE+volumetry MMSE+visual rating
Sensitivity 73 (10) 68 (10)/76 (9) 78 (9)/77 (9)
Specificity 50 (11) 53 (11)/61 (11) 64 (10)/60 (11)
Correct classification 63 (11) 62 (10)/73 (10) 71 (10)/70 (10)
OD=other dementias; AD= Alzheimer’s disease; OD and AD were compared. Sensitivity, specifi-
city and correct classification are given in % (1.96 SE).
Plots of predicted probability (p values) using three logistic regression models to diVerentiate patients with Alzheimer’s disease (AD) from controls (C).
Each circle represents one subject. The cut oV level used was 0.5, and the misclassified subjects are marked.
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between patients with Alzheimer’s disease and
patients with other dementias as well as
between these two groups and non-dementias.
We found the diagnostic accuracy to be very
high for the combination of MMSE and visual
rating of MTA, diVerentiating Alzheimer’s dis-
ease from non-demented patients with a sensi-
tivity of 95% (95% CI 88–98%), a specificity of
98% (95% CI 95–100%), and a correct classi-
fication of 96% (95%CI 92–100%). Our volu-
metric method showed a slightly lower degree
of correct classification (93% (95% CI 86–
98%)) which is in agreement with findings of
other groups. For instance, Laakso et al8
reported an overall correct classification of
92% discriminating Alzheimer’s disease from
controls using volumetry in a slightly larger
sample.
Of special interest is the reasonably high
sensitivity (82 (CI 75–69%)) of MTA for the
diagnosis of other dementias, which included
vascular dementia (n=21), frontal lobe de-
mentia (n=4), and unspecified dementia
(n=11), but were grouped together as other
dementias for statistical reasons versus non-
dementias. As could be expected the MMSE
had low sensitivity for other dementias, but the
added value of MTA suggests medial temporal
lobe involvement in some of these non-
Alzheimer’s disease dementias.20 21 This also
explains the weaker performance of MTA in
discriminating Alzheimer’s disease from other
dementias. Few other studies have considered
the problem of discriminating Alzheimer’s dis-
ease from other dementias using MTA or
MRI. Laakso et al9 have compared Alzheimer’s
disease with Parkinson’s disease (with and
without dementia) and vascular dementia and
found no diVerences between the groups for
medial temporal lobe volumes. Recently,
Frisoni et al10 compared volumetry of the hip-
pocampus and entorhinal cortex in patients
with Alzheimer’s disease and patients with
frontotemporal dementia and found equal
atrophy in the entorhinal cortex but more
severe hippocampal atrophy in Alzheimer’s
disease. However, in all these studies, includ-
ing ours, coexistence of Alzheimer’s disease
and the other dementias could not be ruled
out, despite a follow up period of 6 months in
our study. In a recent study on patients with
histologically confirmed dementia with Lewy
bodies and patients with Alzheimer’s disease;
however, visually rated MTA on MRI was able
to diVerentiate both groups with high
accuracy.22
Our volumetry focused on the MTL, but
visual rating probably also included more
lateral parts, which were found to raise the cor-
rect classification of Alzheimer’s disease from
80% to 91% in a study by De Leon et al.2 This
is further supported by findings from Frisoni et
al23 in which a sensitivity of 85% and specificity
of 95% were found in discriminating patients
with Alzheimer’s disease from controls, using a
combination of the width of temporal horn,
width of choroidal fissure, and height of
hippocampus.
It is not fully evaluated which substructures
of the medial temporal lobes best characterise
Alzheimer’s disease—the entorhinal cortex,24
the hippocampus,8 or both.25 Juottonen et al25
evaluated the discriminative power of the
entorhinal cortex and hippocampus. The
sensitivity in detecting Alzheimer’s disease was
similar for both (80%) but the entorhinal cor-
tex was 3% more specific (94%). Adding sex to
the regression analysis increased the sensitivity
to 90%, but had no influence on specificity.
This illustrates that including other variables
into the discriminant models may increase the
diagnostic accuracy. We also included, apart
from sex and age, MMSE scores into the
discriminative model and when adding rating
and volumetry this resulted in very high sensi-
tivity and specificity.
It could be argued that the comparison of
visual and volumetric analysis is hampered by
using a less valid stereological method instead
of semiautomated manual tracings and by
using a slice thickness of 2.8 mm instead of the
1.5 mm typically seen in studies such as this.
The first argument is dealt with in an earlier
study18 in which we compared both methods
and found that there was a good agreement in
ranking the relative relation between volumes
within the group under study. This means that
the faster stereology method should be compa-
rable with manual outlining methods for sensi-
tivity. Using a smaller slice thickness would
limit the investigation to highly selected
research samples as both scan time and image
analysis time would be significantly increased.
There is also a trade oV between high
resolution (and longer scan time) and move-
ment artifacts, especially in large clinical
samples such as these. The slice thickness we
chose may thus be regarded as a compromise.
Most importantly, the present paper compared
two diVerent methods on the same set of
images. Probably both methods could benefit
from a smaller slice thickness. However, this
was not regarded as a major objective of the
present study.
Taking into account that visual rating is rapid
(1–2 min/subject) and can be applied to all
kind of (coronal) MRI images regardless of
type of imager or protocol, the method could
be implemented into the standard clinical rou-
tines in dementia investigations, provided that
the rater has some experience in visual assess-
ment of MTA.
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